Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole

American Journal of Health-System Pharmacy

Volumn 68, Issue 21, 2011, Pages 2069-2074

  Melkoumov, Alexandre ^a   Soukrati, Amina ^a   Elkin, Igor ^a   Forest, Jean Marc ^b   Hildgen, Patrice ^a   Leclair, Greǵoire ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acidifying agents; Chromatography, liquid; Citric acid; Compounding; Content uniformity; Control, quality; Dissolution; Excipients; Gastrointestinal drugs; Hydrochloric acid; Hydrogen ion concentration; Lansoprazole; Liquids; Sodium bicarbonate; Solvents; Stability; Storage; Sustained action medications; Temperature; Vehicles

Indexed keywords

LANSOPRAZOLE; SODIUM CARBONATE;

ARTICLE; DEGRADATION KINETICS; DELAYED RELEASE FORMULATION; DRUG DEGRADATION; DRUG FORMULATION; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TABLET FRIABILITY; TEMPERATURE MEASUREMENT;

EID: 80455140453     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100634     Document Type: Article

References (17)

1. Prevacid (lansoprazole) product monograph. Saint-Laurent, Canada: Abbott Canada; 2008 Sep.
2. Sharma VK, Ugheoke EA, Vasudeva R et al. Lansoprazole effectively suppresses intragastric acidity when administered via gastrostomy as intact granules in orange juice. Gastroenterology. 1998; 114:A283. Abstract.
3. Chun AH, Eason CJ, Shi HH et al. Lansoprazole: an alternative method of administration of a capsule dosage formulation. Clin Ther. 1995; 17:441-7.
4. Chun AH, Shi HH, Achari R et al. Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube. Clin Ther. 1996; 18:833-42. (Pubitemid 26397282)
5. Sharma VK, Vasudeva R, Howden CW. Simplified lansoprazole suspension (SLS): a proton pump inhibitor (PPI) in a liquid formulation that works. Am J Gastroenterol. 1998; 93:A1647. Abstract.
6. Sharma VK, Vasudeva R, Howden CW. Simplified lansoprazole suspension - a liquid formulation of lansoprazole - effectively suppresses intragastric acidity when administered through a gastrostomy. Am J Gastroenterol. 1999; 94:1813-7. (Pubitemid 29315891)
7. Tso P. Gastrointestinal secretion, digestion and absorption. In: Rhoades RA, Bell DR, eds. Medical physiology: principles for clinical medicine. 3rd ed. Baltimore: Lippincott Williams and Wilkins; 2009:497-529.
8. Kristl A, Vrecer F. Preformulation investigation of the novel proton pump inhibitor lansoprazole. Drug Dev Ind Pharm. 2000; 26:781-3. (Pubitemid 30397335)
9. Sharma VK. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole. Am J Health-Syst Pharm. 1999; 56(suppl 4):S18-21.
10. Sharma VK, Peyton B, Spears T et al. Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate. Aliment Pharmacol Ther. 2000; 14:887-92. (Pubitemid 30446899)
11. Doan TT, Wang Q, Griffin JS et al. Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects. Am J Health-Syst Pharm. 2001; 58:1512-9. (Pubitemid 32756775)
12. Schurizelk BA, Rybron L, Boggild-Madsen NB et al. Gastric volume and pH in children for emergency surgery. Acta Anaesthesiol Scand. 1986; 30:404-8. (Pubitemid 16052821)
13. Kalach N, Badran AM, Jaffray P et al. Correlation between gastric acid secretion and severity of acid reflux in children. Turk J Pediatr. 2003; 45:6-10. (Pubitemid 36347944)
14. Mohammed R, Hearns JB, Crean GP. Gastric acid secretion in children with duodenal ulcer. Scand J Gastroenterol. 1982; 17:289-92. (Pubitemid 12185537)
15. Euler AR, Byrne WJ, Campbell MF. Basal and pentagastrin-stimulated gastric acid secretory rates in normal children and in those with peptic ulcer disease. J Pediatr. 1983; 103:766-8. (Pubitemid 14235445)
16. Collen MJ, Ciarlegio CA, Stanczak VJ. Basal acid output in patients with gastroesophageal reflux disease. Gastroenterology. 1987; 92:1350.
17. Lansoprazole delayed-release capsules monograph. In: The United States pharmacopeia, 33rd rev., and The national formulary, 28th ed. Rockville, MD: United States Pharmacopeial Convention; 2010.